Literature DB >> 23744553

Oxidative DNA damage in Barrett mucosa: correlation with telomeric dysfunction and p53 mutation.

Romilda Cardin1, Marika Piciocchi, Chiara Tieppo, Gemma Maddalo, Giovanni Zaninotto, Claudia Mescoli, Massimo Rugge, Fabio Farinati.   

Abstract

BACKGROUND: Barrett esophagus develops in a scenario of chronic inflammation, linked to free radical formation and oxidative DNA damage. Eight-hydroxydeoxyguanosine, the main oxidative DNA adduct, is partially repaired by a glycosylase (OGG1) whose polymorphism is associated to a reduced repair capacity. Telomeres are particularly prone to oxidative damage, which leads to shortening and cell senescence, while elongation, by telomerase activity, is linked to cell immortalization and cancer. Limited data are available on this point with respect to Barrett esophagus. This study aimed to evaluate the link among 8-hydroxydeoxyguanosine, OGG1 polymorphism, telomerase activity, telomere length, and p53 mutation in Barrett progression.
METHODS: Forty consecutive patients with short- and long-segment Barrett esophagus and 20 controls with gastroesophageal reflux disease without Barrett esophagus were recruited. Analysis of biopsy samples was undertaken to study 8-hydroxydeoxyguanosine levels, OGG1 polymorphism, telomerase activity, and telomere length. Serum samples were obtained for p53 mutation.
RESULTS: Controls had significantly lower levels of 8-hydroxydeoxyguanosine and telomerase activity, with normal telomere length and no p53 mutation. In short-segment Barrett esophagus, 8-hydroxydeoxyguanosine levels were higher and telomeres underwent significant shortening, with stimulation of telomerase activity but no p53 mutations. In long-segment Barrett esophagus, 8-hydroxydeoxyguanosine reached maximal levels, with telomere elongation, and 42 % of the patients showed p53 mutation.
CONCLUSIONS: In Barrett patients, with disease progression, oxidative DNA damage accumulates, causing telomere instability, telomerase activation, and, in a late phase, mutations in the p53 gene, thus abrogating its activity as the checkpoint of proliferation and apoptosis, and facilitating progression to cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23744553     DOI: 10.1245/s10434-013-3043-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  12 in total

1.  Asbestos-induced pulmonary fibrosis is augmented in 8-oxoguanine DNA glycosylase knockout mice.

Authors:  Paul Cheresh; Luisa Morales-Nebreda; Seok-Jo Kim; Anjana Yeldandi; David B Williams; Yuan Cheng; Gökhan M Mutlu; G R Scott Budinger; Karen Ridge; Paul T Schumacker; Vilhelm A Bohr; David W Kamp
Journal:  Am J Respir Cell Mol Biol       Date:  2015-01       Impact factor: 6.914

2.  PDZK1 induces resistance to apoptosis in esophageal adenocarcinoma cells.

Authors:  Osamu Handa; Kyousuke Goda; Yukiko Handa; Shinya Fukushima; Motoyasu Osawa; Takahisa Murao; Hiroshi Matsumoto; Eiji Umegaki; Yoshihiko Fujita; Kazuto Nishio; Akiko Shiotani
Journal:  Esophagus       Date:  2021-02-14       Impact factor: 4.230

3.  Potential Risks in the Paradigm of Basic to Translational Research: A Critical Evaluation of qPCR Telomere Size Techniques.

Authors:  Arthur J Lustig
Journal:  J Cancer Epidemiol Treat       Date:  2015-08-12

4.  Controlled bile acid exposure to oesophageal mucosa causes up-regulation of nuclear γ-H2AX possibly via iNOS induction.

Authors:  Bo Jiang; Shengqian Zhao; Zhen Tao; Jin Wen; Yancheng Yang; Yin Zheng; Hongling Yan; Ying Sheng; Aimin Gao
Journal:  Biosci Rep       Date:  2016-07-07       Impact factor: 3.840

5.  Different requirements of functional telomeres in neural stem cells and terminally differentiated neurons.

Authors:  Anastasia Lobanova; Robert She; Simon Pieraut; Charlie Clapp; Anton Maximov; Eros Lazzerini Denchi
Journal:  Genes Dev       Date:  2017-04-20       Impact factor: 11.361

6.  Association between TP53 gene deletion and protein expression in esophageal squamous cell carcinoma and its prognostic significance.

Authors:  Madiniyet Niyaz; Julaiti Ainiwaer; Abulajiang Abudureheman; Liwei Zhang; Ilyar Sheyhidin; Abduheny Turhong; Ren Cai; Zhichao Hou; Edris Awut
Journal:  Oncol Lett       Date:  2020-06-09       Impact factor: 2.967

Review 7.  Barrett's esophagus and cancer risk: how research advances can impact clinical practice.

Authors:  Massimiliano di Pietro; Durayd Alzoubaidi; Rebecca C Fitzgerald
Journal:  Gut Liver       Date:  2014-07-01       Impact factor: 4.519

8.  Elevated p53 expression levels correlate with tumor progression and poor prognosis in patients exhibiting esophageal squamous cell carcinoma.

Authors:  Kate Huang; Lin Chen; Jiliang Zhang; Zhi Wu; Linhua Lan; Lu Wang; Bin Lu; Yongzhang Liu
Journal:  Oncol Lett       Date:  2014-07-11       Impact factor: 2.967

9.  DNA Damage in CD133-Positive Cells in Barrett's Esophagus and Esophageal Adenocarcinoma.

Authors:  Raynoo Thanan; Ning Ma; Yusuke Hiraku; Katsunori Iijima; Tomoyuki Koike; Tooru Shimosegawa; Mariko Murata; Shosuke Kawanishi
Journal:  Mediators Inflamm       Date:  2016-03-10       Impact factor: 4.711

Review 10.  Current research progress in the role of reactive oxygen species in esophageal adenocarcinoma.

Authors:  Youzhen Hu; Xiaojun Ye; Ruihua Wang; Karen Poon
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.